(SAN JOSE, CALIFORNIA – JUNE 1, 2019) – Danaher’s Life Sciences platform today announced Greg Milosevich has been appointed to the role of President, Beckman Coulter Life Sciences. In his new role, Greg will lead the Beckman Coulter Life Sciences strategy to grow the business and advance its position as a market leader.

Greg’s Danaher career spans more than 10 years. Most recently, Greg served as President of Molecular Devices where he significantly accelerated growth, and led the acquisition and integration of IDBS and the ForteBio business unit. Prior to leading Molecular Devices, Greg served as Vice President & General Manager of Molecular Devices Global Commercial Operations (2013 – 2015) and Western Markets (2010-2012). He also held Molecular Devices’ sales leadership positions in both the Americas (2007 – 2010) and Emerging Markets (2006 – 2007).

Greg holds a Bachelor of Science in Physics from the University of Puget Sound. He will continue to be based in San Jose, CA.